Hostname: page-component-74656f9884-6grmk Total loading time: 0 Render date: 2026-11-05T21:32:40.795Z Has data issue: false hasContentIssue false

Haemonchus contortus as a paradigm and model to study anthelmintic drug resistance

Published online by Cambridge University Press:  02 September 2013

JOHN S. GILLEARD*
Affiliation:
Department of Comparative Biology and Experimental Medicine, Faculty of Veterinary Medicine, 3280, Hospital Drive NW, University of Calgary, Calgary, Alberta, T2N 4Z6, Canada
*
*Corresponding author: Department of Comparative Biology and Experimental Medicine, Faculty of Veterinary Medicine, 3280, Hospital Drive NW, University of Calgary, Calgary, Alberta, T2N 4Z6, Canada. Tel: 403 210 6327. Fax: 403 210 6693. E-mail: jsgillea@ucalgary.ca
Rights & Permissions [Opens in a new window]

Summary

Anthelmintic resistance is a major problem for the control livestock parasites and a potential threat to the sustainability of community-wide treatment programmes being used to control human parasites in the developing world. Anthelmintic resistance is essentially a complex quantitative trait in which multiple mutations contribute to the resistance phenotype in an additive manner. Consequently, a combination of forward genetic and genomic approaches are needed to identify the causal mutations and quantify their contribution to the resistance phenotype. Therefore, there is a need to develop genetic and genomic approaches for key parasite species identified as relevant models. Haemonchus contortus, a gastro-intestinal parasite of sheep, has shown a remarkable propensity to develop resistance to all the drugs used in its control. Partly because of this, and partly because of its experimental amenability, research on this parasite has contributed more than any other to our understanding of anthelmintic resistance. H. contortus offers a variety of advantages as an experimental system including the ability to undertake genetic crosses; a prerequisite for genetic mapping. This review will discuss the current progress on developing H. contortus as a model system in which to study anthelmintic resistance.

Information

Type
Research Article
Copyright
Copyright © Cambridge University Press 2013 
Figure 0

Fig. 1. Summary of the use of H. contortus as a model system in which to study the genetic basis of anthelmintic resistance.

Figure 1

Fig. 2. The relevance of H. contortus population size to the origins of anthelmintic resistance mutations.

Figure 2

Fig. 3. Schematic representation of two different crossing regimes applied to H. contortus. A single resistance conferring locus is represented by * on a single chromosome pair to illustrate the general concepts. In reality, there are likely to be multiple loci on multiple chromosomes acting as Quantitative Trait Loci in an additive manner. The parental chromosomes from the resistant parent are represented in red and from the susceptible parent in blue. (A) F2 mapping approach; (B) Serial backcrossing approach.

Figure 3

Fig. 4. Experimental design of the serial backcross. Crosses were performed by surgically transplanting immature adult female worms of an ivermectin resistant H. contortus strain, MHco10(CAVR), and immature adult male worms of the ivermectin susceptible reference strain, MHco3(ISE), into the abomasum of a recipient sheep. This methodology ensures that the only progeny produced are the product of a cross between the two different strains. After the first cross between the two parental strains, the F1 progeny of each cross is repeatedly backcrossed against the MHco3(ISE) susceptible reference strain using the same procedure.

Figure 4

Fig. 5. Genetic validation of the serial backcrossing procedure. (A) Diagrammatic representation the genetics of the serial backcross experiment. The parental strains are genetically divergent and so their genomes are represented by different colours; red for the MHco10(CAVR) ivermectin resistant strain and blue for the MHco3(ISE) susceptible reference strain. After four generations of serial backcrossing against the MHco3(ISE) strain, in the presence of ivermectin selection, regions of the MHco10(CAVR) genome containing ivermectin resistance loci have been introgressed into a predominantly MHco3(ISE) genetic background; (B and C): Genetic data validating the success of the serial backcross. These figures show the genetic validation of the of the serial backcross of the MHco10(CAVR) strain against the MHco3(ISE) susceptible strain. Thirty worms from each of the two parental strains, thirty worms from the fourth generation backcross progeny (no drug treatment) and thirty worms of the fourth generation backcross progeny that survived 0·1 mg/kg ivermectin treatment were genotyped with a panel of neutral microsatellite markers. Figure 5B shows pairwise FST estimates. Values below the diagonal are from the analysis of nine microsatellite loci and above the diagonal for eight microsatellite loci (when marker Hcms8a20 was excluded since it showed evidence of genetic linkage to the ivermectin resistance phenotype). Values showing genetic differentiation between strains at significance level P⩽0·01 are shown in red. The key results are circled that demonstrate the fourth generation backcross worms which survived ivermectin treatment are much more genetically similar to the susceptible MHco3(ISE) parental strain than to the resistant MHco10(CAVR) parental strain. Figure 5C shows the PCA analysis where each data point represents a single worm based on a multi-locus genotype of nine microsatellite markers. Note how the fourth generation backcross worms (with an ivermectin resistant phenotype) cluster with worms the MHco3(ISE) susceptible parental strain rather than with worms from the MHco10(CAVR) ivermectin resistant parental. These results show that fourth generation backcross worms with an ivermectin resistant phenotype have a genetic background predominantly from the MHco3(ISE) ivermectin susceptible parental strain.